1887

Abstract

Bacillary angiomatosis is a well-recognized infection with cutaneous and systemic manifestations caused by or and occurs in immunocompromised patients. We report a case of bacillary angiomatosis following fludarabine-based chemotherapy for chronic lymphocytic leukaemia that was refractory to standard treatment and was complicated by lymphadenopathy and osteomyelitis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.015867-0
2011-01-01
2020-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/1/142.html?itemId=/content/journal/jmm/10.1099/jmm.0.015867-0&mimeType=html&fmt=ahah

References

  1. Alsmark, C. M., Frank, A. C., Karlberg, E. O., Legault, B.-A., Ardell, D. H., Canback, B., Eriksson, A.-S., Naslund, A. K., Handley, S. A. & other authors ( 2004; ). The louse-borne human pathogen Bartonella quintana is a genomic derivative of the zoonotic agent Bartonella henselae. Proc Natl Acad Sci U S A 101, 9716–9721.[CrossRef]
    [Google Scholar]
  2. Anaissie, E. J., Kontoyiannis, D. P., O'Brien, S., Kantarjian, H., Robertson, L., Lerner, S. & Keating, M. J. ( 1998; ). Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 129, 559–566.[CrossRef]
    [Google Scholar]
  3. Anderson, B., Sims, K., Regnery, R., Robinson, L., Schmidt, M. J., Goral, S., Hager, C. & Edwards, K. ( 1994; ). Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J Clin Microbiol 32, 942–948.
    [Google Scholar]
  4. Bergmann, L., Fenchel, K., Jahn, B., Mitrou, P. S. & Hoelzer, D. ( 1993; ). Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann Oncol 4, 371–375.
    [Google Scholar]
  5. Bonatti, H., Mendez, J., Guerrero, I., Krishna, M., Ananda-Michel, J., Yao, J., Steers, J. L., Hellinger, W., Dickson, R. C. & Alvarez, S. ( 2006; ). Disseminated Bartonella infection following liver transplantation. Transpl Int 19, 683–687.[CrossRef]
    [Google Scholar]
  6. Brouqui, P., Lascola, B., Roux, V. & Raoult, D. ( 1999; ). Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med 340, 184–189.[CrossRef]
    [Google Scholar]
  7. Chang, C.-C., Chomel, B. B., Kasten, R. W., Tappero, J. W., Sanchez, M. A. & Koehler, J. E. ( 2002; ). Molecular epidemiology of Bartonella henselae infection in human immunodeficiency virus-infected patients and their cat contacts, using pulsed-field gel electrophoresis and genotyping. J Infect Dis 186, 1733–1739.[CrossRef]
    [Google Scholar]
  8. Chapel, H. M. & Bunch, C. ( 1987; ). Mechanisms of infection in chronic lymphocytic leukemia. Semin Hematol 24, 291–296.
    [Google Scholar]
  9. Chomel, B. B., Boulouis, H.-J., Maruyama, S. & Breitschwerdt, E. B. ( 2006; ). Bartonella spp. in pets and effect on human health. Emerg Infect Dis 12, 389–394.[CrossRef]
    [Google Scholar]
  10. Dörbecker, C., Sander, A., Oberle, K. & Schülin-Casonato, T. ( 2006; ). In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution. J Antimicrob Chemother 58, 784–788.[CrossRef]
    [Google Scholar]
  11. Fabbi, M., De Giuli, L., Tranquillo, M., Bragoni, R., Casiraghi, M. & Genchi, C. ( 2004; ). Prevalence of Bartonella henselae in Italian stray cats: evaluation of serology to assess the risk of transmission of Bartonella to humans. J Clin Microbiol 42, 264–268.[CrossRef]
    [Google Scholar]
  12. Foucault, C., Raoult, D. & Brouqui, P. ( 2003; ). Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother 47, 2204–2207.[CrossRef]
    [Google Scholar]
  13. Foucault, C., Brouqui, P. & Raoult, D. ( 2006; ). Bartonella quintana characteristics and clinical management. Emerg Infect Dis 12, 217–223.[CrossRef]
    [Google Scholar]
  14. Gasquet, S., Maurin, M., Brouqui, P., Lepidi, H. & Raoult, D. ( 1998; ). Bacillary angiomatosis in immunocompromised patients. AIDS 12, 1793–1803.[CrossRef]
    [Google Scholar]
  15. Holmes, N. E., Hodgkinson, M., Dendle, C. & Korman, T. M. ( 2008; ). Report of oral clarithromycin desensitization. Br J Clin Pharmacol 66, 323–324.[CrossRef]
    [Google Scholar]
  16. Koehler, J. E. & Tappero, J. W. ( 1993; ). Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 17, 612–624.[CrossRef]
    [Google Scholar]
  17. Koehler, J. E., Sanchez, M. A., Garrido, C. S., Whitfeld, M. J., Chen, F. M., Berger, T. G., Rodriguez-Barradas, M. C., Leboit, P. E. & Tappero, J. W. ( 1997; ). Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med 337, 1876–1883.[CrossRef]
    [Google Scholar]
  18. La Scola, B. & Raoult, D. ( 1996; ). Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J Clin Microbiol 34, 2270–2274.
    [Google Scholar]
  19. La Scola, B. & Raoult, D. ( 1999; ). Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol 37, 1899–1905.
    [Google Scholar]
  20. Mantadakis, E., Spanaki, A.-M., Psaroulaki, A., Fitrolaki, D., Minadakis, G., Michaeloudi, E., Tselentis, Y. & Briassoulis, G. ( 2007; ). Encephalopathy complicated by Guillain-Barre syndrome and hydrocephalus and associated with acute Bartonella quintana infection. Pediatr Infect Dis J 26, 860–862.[CrossRef]
    [Google Scholar]
  21. Margileth, A. M. ( 2000; ). Recent advances in diagnosis and treatment of cat scratch disease. Curr Infect Dis Rep 2, 141–146.[CrossRef]
    [Google Scholar]
  22. Maurin, M. & Raoult, D. ( 1996; ). Bartonella (Rochalimaea) quintana infections. Clin Microbiol Rev 9, 273–292.
    [Google Scholar]
  23. Maurin, M. & Raoult, D. ( 1998; ). Bartonella infections: diagnostic and management issues. Curr Opin Infect Dis 11, 189–193.[CrossRef]
    [Google Scholar]
  24. Maurin, M., Birtles, R. & Raoult, D. ( 1997; ). Current knowledge of Bartonella species. Eur J Clin Microbiol Infect Dis 16, 487–506.[CrossRef]
    [Google Scholar]
  25. Meghari, S., Rolain, J.-M., Grau, G. E., Platt, E., Barrassi, L., Mege, J.-L. & Raoult, D. ( 2006; ). Antiangiogenic effect of erythromycin: an in vitro model of Bartonella quintana infection. J Infect Dis 193, 380–386.[CrossRef]
    [Google Scholar]
  26. Milde, P., Brunner, M., Borchard, F., Sudhoff, T., Burk, M., Zumdick, M., Goerz, G. & Ruzicka, T. ( 1995; ). Cutaneous bacillary angiomatosis in a patient with chronic lymphocytic leukemia. Arch Dermatol 131, 933–936.[CrossRef]
    [Google Scholar]
  27. Mohle-Boetani, J. C., Koehler, J. E., Berger, T. G., Leboit, P. E., Kemper, C. A., Reingold, A. L., Plikaytis, B. D., Wenger, J. D. & Tappero, J. W. ( 1996; ). Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. Clin Infect Dis 22, 794–800.[CrossRef]
    [Google Scholar]
  28. O'Brien, S., Kantarjian, H., Beran, M., Smith, T., Koller, C., Estey, E., Robertson, L. E., Lerner, S. & Keating, M. ( 1993; ). Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 82, 1695–1700.
    [Google Scholar]
  29. Petersen, K., Earhart, K. & Wallace, M. ( 2008; ). Bacillary angiomatosis in a patient with chronic lymphocytic leukemia. Infection 36, 480–484.[CrossRef]
    [Google Scholar]
  30. Raoult, D., Fournier, P. E., Vandenesch, F., Mainardi, J. L., Eykyn, S. J., Nash, J., James, E., Benoit-Lemercier, C. & Marrie, T. J. ( 2003; ). Outcome and treatment of Bartonella endocarditis. Arch Intern Med 163, 226–230.[CrossRef]
    [Google Scholar]
  31. Rathbone, P., Graves, S., Miller, D., Odorico, D., Jones, S., Hellyar, A., Sinickas, V. & Grigg, A. ( 1996; ). Bartonella (Rochalimaea) quintana causing fever and bacteremia in an immunocompromised patient with non-Hodgkin's lymphoma. Pathology 28, 80–83.[CrossRef]
    [Google Scholar]
  32. Rolain, J. M., Maurin, M. & Raoult, D. ( 2000; ). Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications. J Antimicrob Chemother 46, 811–814.[CrossRef]
    [Google Scholar]
  33. Rolain, J. M., Brouqui, P., Koehler, J. E., Maguina, C., Dolan, M. J. & Raoult, D. ( 2004; ). Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 48, 1921–1933.[CrossRef]
    [Google Scholar]
  34. Sander, A., Posselt, M., Oberle, K. & Bredt, W. ( 1998; ). Seroprevalence of antibodies to Bartonella henselae in patients with cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests. Clin Diagn Lab Immunol 5, 486–490.
    [Google Scholar]
  35. Schwartz, R. A., Nychay, S. G., Janniger, C. K. & Lambert, W. C. ( 1997; ). Bacillary angiomatosis: presentation of six patients, some with unusual features. Br J Dermatol 136, 60–65.[CrossRef]
    [Google Scholar]
  36. Tappero, J. W., Koehler, J. E., Berger, T. G., Cockerell, C. J., Lee, T. H., Busch, M. P., Stites, D. P., Mohle-Boetani, J., Reingold, A. L. & Leboit, P. E. ( 1993; ). Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med 118, 363–365.[CrossRef]
    [Google Scholar]
  37. Tea, A., Alexiou-Daniel, S., Arvanitidou, M., Diza, E. & Antoniadis, A. ( 2003; ). Occurrence of Bartonella henselae and Bartonella quintana in a healthy Greek population. Am J Trop Med Hyg 68, 554–556.
    [Google Scholar]
  38. Török, L., Virágh, S. Z., Borka, I. & Tápai, M. ( 1994; ). Bacillary angiomatosis in a patient with lymphocytic leukaemia. Br J Dermatol 130, 665–668.[CrossRef]
    [Google Scholar]
  39. Vermeulen, M. J., Herremans, M., Verbakel, H., Bergmans, A. M. C., Roord, J. J., Van Dijken, P. J. & Peeters, M. F. ( 2007; ). Serological testing for Bartonella henselae infections in The Netherlands: clinical evaluation of immunofluorescence assay and ELISA. Clin Microbiol Infect 13, 627–634.[CrossRef]
    [Google Scholar]
  40. Wijermans, P. W., Gerrits, W. B. & Haak, H. L. ( 1993; ). Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol 50, 292–296.
    [Google Scholar]
  41. Woolley, M. W., Gordon, D. L. & Wetherall, B. L. ( 2007; ). Analysis of the first Australian strains of Bartonella quintana reveals unique genotypes. J Clin Microbiol 45, 2040–2043.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.015867-0
Loading
/content/journal/jmm/10.1099/jmm.0.015867-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error